Evidence map›Paper›PMID 31710311›Full record

ArticleThe Journal of clinical investigation2019

High-fat diet exacerbates SIV pathogenesis and accelerates disease progression.

Tianyu He, Cuiling Xu, Noah Krampe, Stephanie M Dillon, Paola Sette, Elizabeth Falwell, George S Haret-Richter, Tiffany Butterfield, Tammy L Dunsmore, William M McFadden and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Multimorbidity and animal models.Animal models and experimental medicine · 2025
    Review
  9. Article
  10. EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Tianyu HeCenter for Vaccine Research.
Cuiling XuCenter for Vaccine Research.
Noah KrampeCenter for Vaccine Research.
Stephanie M DillonDivision of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Paola SetteCenter for Vaccine Research.
Elizabeth FalwellCenter for Vaccine Research.
George S Haret-RichterCenter for Vaccine Research.
Tiffany ButterfieldDepartment of Microbial Pathogens and Immunity, Rush University, Chicago, Illinois, USA.
Tammy L DunsmoreCenter for Vaccine Research.
William M McFaddenCenter for Vaccine Research.
Kathryn J MartinCenter for Vaccine Research.
Benjamin B PolicicchioCenter for Vaccine Research.
Kevin D RaehtzCenter for Vaccine Research.
Ellen P PennCenter for Vaccine Research.
Russell P TracyDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.
Ruy M RibeiroLos Alamos National Laboratory, Los Alamos, New Mexico, USA.
Daniel N FrankDivision of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Cara C WilsonDivision of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Alan L LandayDepartment of Microbial Pathogens and Immunity, Rush University, Chicago, Illinois, USA.
Cristian ApetreiCenter for Vaccine Research.
Ivona PandreaCenter for Vaccine Research.
Institut de Recherche Vaccinale · FRUniversity of Pittsburgh · USUniversity of Colorado Anschutz Medical Campus · USRush University · USLos Alamos National Laboratory · USUniversity of Vermont · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Using Dengue Controlled Human Infection Model to Identify Adaptive Immune Correlates of ProtectionP20GM125498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Ellen Kozelka · 2018 to 2026
$24.9M
SIV Pathogenesis in African Green Monkeys and Pigtailed MacaquesR01HL117715 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2012 to 2021
$7.0M
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPsR01HL123096 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2015 to 2025
$6.8M
Assessing the Role of GI Tract Dysfunction to HIV/SIV Disease ProgressionR01DK113919 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CRISTIAN APETREI, Ivona Vasile-Pandrea · 2017 to 2026
$5.7M
New Strategy to Improve Gastrointestinal Health in SIV/HIVR01DK119936 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2018 to 2022
$5.1M
Animal Model for Testing SIV Latency Reversal StrategiesR01AI119346 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2015 to 2019
$3.4M
PITT AIDS RESEARCH TRAINING PROGRAMT32AI065380 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BARRATT-BOYES, SIMON M · 2005 to 2020
$3.2M
Quantifying Immune VS. Viral Killing of SIV Infected and Latently Infected CellsR01AI104373 · NIAID · LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB · PI RIBEIRO, RUY M · 2013 to 2016
$2.7M
Animal Model for SIV Infection ControlR01RR025781 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN, VASILE PANDREA, IVONA · 2009 to 2010
$1.9M
NCRR NIH HHS R01 RR025781NHLBI NIH HHS R01 HL117715NHLBI NIH HHS R01 HL123096NIAID NIH HHS R01 AI104373NIAID NIH HHS R01 AI119346NIAID NIH HHS T32 AI065380NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK113919NIDDK NIH HHS R01 DK119936NIGMS NIH HHS P20 GM125498
6 · The paper itself

Abstract

Consuming a high-fat diet (HFD) is a risk factor for obesity and diabetes; both of these diseases are also associated with systemic inflammation, similar to HIV infection. A HFD induces intestinal dysbiosis and impairs liver function and coagulation, with a potential negative impact on HIV/SIV pathogenesis. We administered a HFD rich in saturated fats and cholesterol to nonpathogenic (African green monkeys) and pathogenic (pigtailed macaques) SIV hosts. The HFD had a negative impact on SIV disease progression in both species. Thus, increased cell-associated SIV DNA and RNA occurred in the HFD-receiving nonhuman primates, indicating a potential reservoir expansion. The HFD induced prominent immune cell infiltration in the adipose tissue, an important SIV reservoir, and heightened systemic immune activation and inflammation, altering the intestinal immune environment and triggering gut damage and microbial translocation. Furthermore, HFD altered lipid metabolism and HDL oxidation and also induced liver steatosis and fibrosis. These metabolic disturbances triggered incipient atherosclerosis and heightened cardiovascular risk in the SIV-infected HFD-receiving nonhuman primates. Our study demonstrates that dietary intake has a discernable impact on the natural history of HIV/SIV infections and suggests that dietary changes can be used as adjuvant approaches for HIV-infected subjects, to reduce inflammation and the risk of non-AIDS comorbidities and possibly other infectious diseases.

Indexed as

Adipose TissueAnimalsBacterial TranslocationCardiovascular DiseasesChlorocebus aethiopsDiet, High-FatDisease ProgressionInflammationLiverSimian Acquired Immunodeficiency SyndromeAdaptive immunityAIDS/HIVCardiovascular diseaseCholesterol

Identifiers

PMID31710311
PMCPMC6877342
OpenAlexW2984034208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.